Culture-Based Methods and Molecular Tools for Azole-Resistant Aspergillus fumigatus Detection in a Belgian University Hospital

Journal of Clinical Microbiology
I MontesinosK Lagrou

Abstract

Azole-resistant Aspergillus fumigatus is an increasing worldwide problem with major clinical implications. Surveillance is warranted to guide clinicians to provide optimal treatment to patients. To investigate azole resistance in clinical Aspergillus isolates in our institution, a Belgian university hospital, we conducted a laboratory-based surveillance between June 2015 and October 2016. Two different approaches were used: a prospective culture-based surveillance using VIPcheck on unselected A. fumigatus (n = 109 patients, including 19 patients with proven or probable invasive aspergillosis [IA]), followed by molecular detection of mutations conferring azole resistance, and a retrospective detection of azole-resistant A. fumigatus in bronchoalveolar lavage fluid using the commercially available AsperGenius PCR (n = 100 patients, including 29 patients with proven or probable IA). By VIPcheck, 25 azole-resistant A. fumigatus specimens were isolated from 14 patients (12.8%). Of these 14 patients, only 2 had proven or probable IA (10.5%). Mutations at the cyp51A gene were observed in 23 of the 25 A. fumigatus isolates; TR34/L98H was the most prevalent mutation (46.7%), followed by TR46/Y121F/T289A (26.7%). Twenty-seven (27%) patie...Continue Reading

References

Jan 29, 2000·British Journal of Haematology·E C WilliamsonM R Millar
Feb 27, 2003·Antimicrobial Agents and Chemotherapy·T M Diaz-GuerraJ L Rodriguez-Tudela
Sep 27, 2005·The Lancet Infectious Diseases·W W HopeD W Denning
Jan 20, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Lewis WhiteRosemary A Barnes
Jan 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshUNKNOWN Infectious Diseases Society of America
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Jul 25, 2009·Emerging Infectious Diseases·Susan J HowardDavid W Denning
Nov 21, 2009·The Lancet Infectious Diseases·Paul E VerweijWillem J G Melchers
Apr 13, 2011·Clinical Microbiology Reviews·Thomas F O'Brien, John Stelling
Oct 18, 2011·Emerging Infectious Diseases·Jan W M van der LindenPaul E Verweij
Nov 30, 2011·Antimicrobial Agents and Chemotherapy·Pierre-Régis BurgelAndré Paugam
May 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan W M van der LindenPaul E Verweij
May 15, 2013·Antimicrobial Agents and Chemotherapy·Oliver BaderUNKNOWN MykoLabNet-D Partners
May 24, 2013·Emerging Infectious Diseases·Seyedmojtaba SeyedmousaviPaul E Verweij
Aug 3, 2014·The Journal of Antimicrobial Chemotherapy·Isabel MontesinosOlivier Denis
Jan 30, 2015·The Journal of Antimicrobial Chemotherapy·J SteinmannP-M Rath
Apr 18, 2015·Mycoses·Sarah E KiddPaul E Verweij
May 20, 2015·Antimicrobial Agents and Chemotherapy·Edith VermeulenKatrien Lagrou
May 20, 2015·Emerging Infectious Diseases·J W M van der LindenP E Verweij
Jun 27, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Lewis WhiteJ Peter Donnelly
Jul 15, 2015·The Journal of Antimicrobial Chemotherapy·J FuhrenJ G Kusters
Aug 19, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Paul E VerweijJ Peter Donnelly
Feb 24, 2016·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Daisuke HagiwaraKatsuhiko Kamei
Apr 20, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R H JensenM C Arendrup
Aug 6, 2016·The Journal of Antimicrobial Chemotherapy·Paul E VerweijJacques F Meis
Aug 20, 2016·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Judith van PaassenEduard J Kuijper
Oct 6, 2016·Infection and Drug Resistance·Pierre-Régis BurgelClémence Martin
Jan 13, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Jacques F MeisPaul E Verweij

❮ Previous
Next ❯

Citations

Feb 7, 2018·Current Infectious Disease Reports·Ilan S Schwartz, Thomas F Patterson
Nov 1, 2017·Medical Mycology·Rosemary A BarnesJ Peter Donnelly
Jun 21, 2019·The Journal of Antimicrobial Chemotherapy·Maria F Gonzalez-LaraAreli Martinez-Gamboa
Jul 23, 2019·Medical Mycology·Beatriz BustamantePablo E Campos
Jan 16, 2020·Journal of Fungi·Mireille H van der TorreRiina Rautemaa-Richardson
Apr 6, 2018·Frontiers in Microbiology·Jochem B BuilWillem J G Melchers
Jun 27, 2019·The Journal of Antimicrobial Chemotherapy·Agustin Resendiz-SharpeKatrien Lagrou
May 1, 2020·Clinical Microbiology Reviews·Elizabeth L BerkowLuis Ostrosky-Zeichner
May 10, 2018·Frontiers in Microbiology·Peter-Michael Rath, Joerg Steinmann
Apr 7, 2021·Antimicrobial Agents and Chemotherapy·Jan Struckmann PoulsenJeppe Lund Nielsen
May 27, 2021·Studies in Mycology·A ArastehfarM Hoenigl
Sep 12, 2021·The Journal of Antimicrobial Chemotherapy·Monica A SlavinJohan A Maertens
Sep 2, 2019·Médecine et maladies infectieuses·A JeanvoineL Millon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.